We further showed that the ablation of ATF6 or inactivation of EGF signaling are promising strategies to break the interplay between dormant cancer cells and their microenvironment, thereby inhibiting the angiogenesis-mediated awakening of dormant cancer cells. Here, EGF is linked to cancer.